Study identifier:NIS-ODE-ARI-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Arimidex: Compliance and arthralgias in clinical therapy (COMPACT): An in practice assessment of arthralgias and related costs as well as compliance in the first year of anastrozole therapy
Breast Cancer
-
No
-
Female
2313
Observational
18 Years +
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
All patients treated with Anastrozole as per SPC | - |